Melissa Bradford-Klug

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.

Part of Harrow, Inc., Mayfield Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Las Vegas, NV. The CEO of the company is Melissa Bradford-Klug.

Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015.

Part of Citrine Pharmaceutical (Shanghai) Co., Ltd., Citrine Medicine, Inc. is a company that focuses on disseminating information about rare disease treatment and self-management through internet platforms. The company is based in Cambridge, MA. The company also operates and promote medical devices, provide online information consulting services, and offer health insurance services. The company aims to create the first communication platform in China that shares experiences and journeys in treating rare diseases.